Nalcioglu O - Search Results

1

Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon.

Agrawal G, Su MY, Nalcioglu O, Feig SA, Chen JH. Agrawal G, et al. Among authors: nalcioglu o. Cancer. 2009 Apr 1;115(7):1363-80. doi: 10.1002/cncr.24156. Cancer. 2009. PMID: 19197974 Free PMC article.

2

Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring.

Su MY, Yu H, Chiou JY, Wang J, Nalcioglu O, Fruehauf JP, Mehta RS, Baick CH. Su MY, et al. Among authors: nalcioglu o. Technol Cancer Res Treat. 2002 Dec;1(6):479-88. doi: 10.1177/153303460200100608. Technol Cancer Res Treat. 2002. PMID: 12625775 Free article.

3

Resolution improvement in positron emission tomography using anatomical Magnetic Resonance Imaging.

Chu Y, Su MY, Mandelkern M, Nalcioglu O. Chu Y, et al. Among authors: nalcioglu o. Technol Cancer Res Treat. 2006 Aug;5(4):311-7. doi: 10.1177/153303460600500402. Technol Cancer Res Treat. 2006. PMID: 16866561 Free article.

4

Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.

Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O. Su MY, et al. Among authors: nalcioglu o. Technol Cancer Res Treat. 2006 Aug;5(4):401-10. Technol Cancer Res Treat. 2006. PMID: 16866570

5

MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy.

Yu HJ, Chen JH, Mehta RS, Nalcioglu O, Su MY. Yu HJ, et al. Among authors: nalcioglu o. J Magn Reson Imaging. 2007 Sep;26(3):615-23. doi: 10.1002/jmri.21060. J Magn Reson Imaging. 2007. PMID: 17729334

6

MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy.

Chen JH, Feig B, Agrawal G, Yu H, Carpenter PM, Mehta RS, Nalcioglu O, Su MY. Chen JH, et al. Among authors: nalcioglu o. Cancer. 2008 Jan 1;112(1):17-26. doi: 10.1002/cncr.23130. Cancer. 2008. PMID: 18000804 Free article. Clinical Trial.

7

Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer.

Baek HM, Yu HJ, Chen JH, Nalcioglu O, Su MY. Baek HM, et al. Among authors: nalcioglu o. Magn Reson Imaging. 2008 May;26(4):523-31. doi: 10.1016/j.mri.2007.10.002. Epub 2007 Dec 3. Magn Reson Imaging. 2008. PMID: 18060716 Free PMC article.

8

Estrogen receptor and breast MR imaging features: a correlation study.

Chen JH, Baek HM, Nalcioglu O, Su MY. Chen JH, et al. Among authors: nalcioglu o. J Magn Reson Imaging. 2008 Apr;27(4):825-33. doi: 10.1002/jmri.21330. J Magn Reson Imaging. 2008. PMID: 18383260 Free PMC article.

9

Magnetic resonance imaging features of fibrocystic change of the breast.

Chen JH, Liu H, Baek HM, Nalcioglu O, Su MY. Chen JH, et al. Among authors: nalcioglu o. Magn Reson Imaging. 2008 Nov;26(9):1207-14. doi: 10.1016/j.mri.2008.02.004. Epub 2008 Apr 23. Magn Reson Imaging. 2008. PMID: 18436406 Free PMC article.

10

Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI.

Nie K, Chen JH, Yu HJ, Chu Y, Nalcioglu O, Su MY. Nie K, et al. Among authors: nalcioglu o. Acad Radiol. 2008 Dec;15(12):1513-25. doi: 10.1016/j.acra.2008.06.005. Acad Radiol. 2008. PMID: 19000868 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters